NCT05332561 2025-03-20
Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)
German Cancer Research Center
Phase 2 Recruiting
Clinical Trials
7 trialsNCT05498896 2025-03-10
BARBICAN
Queen Mary University of London
Phase 2 Active not recruiting
NCT04464174 2024-07-26
PATHFINDER
MedSIR
Phase 2 Completed
NCT03395899 2024-06-18
ECLIPSE
Queen Mary University of London
Phase 2 Completed
NCT04920708 2023-10-27
FAIM
Royal Marsden NHS Foundation Trust
Phase 2 Recruiting
NCT04591431 2023-10-03
ROME
Fondazione per la Medicina Personalizzata
Phase 2 Unknown
NCT02301988 2018-10-17
A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast Cancer
Genentech, Inc.
Phase 2 Completed